M. Katz

Immunomonitoring of Stage IV Relapsed Neuroblastoma Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation and Subsequent GD2 (ch14.18/CHO) Antibody Treatment

C. Seitz, R. Handgretinger, H. Lode, 2021, Frontiers in Immunology.

Discovery and Optimization of Quinolinone Derivatives as Potent, Selective and Orally Bioavailable mutant Isocitrate Dehydrogenase 1 (mIDH1) Inhibitors.

Mark T. Kershaw, S. Ashwell, K. Bair, 2019, Journal of medicinal chemistry.

Structure-based design and identification of FT-2102 (olutasidenib), a potent mutant-selective IDH1 inhibitor.

Mark T. Kershaw, S. Ashwell, D. Walker, 2020, Journal of medicinal chemistry.

USP28 deletion and small-molecule inhibition destabilizes c-MYC and elicits regression of squamous cell lung carcinoma

Andreas C. Damianou, A. Damianou, Claire Heride, 2020, bioRxiv.

The deubiquitylase USP9X controls ribosomal stalling

Claire Heride, D. Komander, A. Behrens, 2020, bioRxiv.

deletion and small molecule inhibition destabilises c-MYC and elicits 1 regression of squamous cell lung carcinoma 2 3

Kearns, Andreas C. Damianou, D. Komander, 2022 .